Roche Holding Ltd ADR (RHHBY)
Roche Holding Ltd ADR is a depositary receipt tied to Roche Holding AG, a Swiss healthcare company with listed exposure to its underlying common shares. Through its pharmaceutical and diagnostics businesses, Roche serves customers across Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. Its pharmaceutical portfolio covers treatment areas including anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune conditions, neurological disorders, ophthalmology, respiratory disorders, and transplantation. The diagnostics segment provides in vitro tests used in the assessment of diseases such as cancer, diabetes, Covid-19, hepatitis, and human papillomavirus, along with diagnostic instruments and digital health solutions. Roche was founded in 1896 and is headquartered in Basel, Switzerland.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-RHHB.Y
|
$52.70
|
3.1% Upside
|
Fair
|
$56.66
|
10.9% Upside
|
Fair
|
Great
|
—
|
—
|
0.97
|
1.9%
|
July 23, 2026
|
—
|
—
|
—
|
326.4 B
|
—
|
11.0%
|
82.1%
|
8.9
|
60.0%
|
—
|
